These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1356 related items for PubMed ID: 19577853

  • 1. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D, Turkmenoglu TT, Kabukcuoglu F.
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [Abstract] [Full Text] [Related]

  • 2. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR, Min SK, Cho HD, Kim KH, Shin HS, Park YE.
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [Abstract] [Full Text] [Related]

  • 3. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D, Boricic I, Todorovic V, Tomanovic N, Radojevic S.
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR, Min SK, Min K, Jun SY, Seo J, Kim KH, Choi J.
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O, Salama M, Meier F, Chaffins M, Ma C, Ormsby A, Lee M.
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
    Kim KH, Park EJ, Seo YJ, Cho HS, Kim CW, Kim KJ, Park HR.
    J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
    [Abstract] [Full Text] [Related]

  • 7. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
    Takahara M, Chen S, Kido M, Takeuchi S, Uchi H, Tu Y, Moroi Y, Furue M.
    J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
    Zhang X, Egawa K, Xie Y, Ihn H.
    Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T, Zamolo G, Coklo M, Hadzisejdic I, Stemberger C, Zauhar G.
    Pathol Res Pract; 2006 Jun; 202(8):599-607. PubMed ID: 16781827
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease.
    Bagazgoitia L, Cuevas J, Juarranz A.
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076
    [Abstract] [Full Text] [Related]

  • 16. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.
    Einspahr JG, Xu MJ, Warneke J, Saboda K, Ranger-Moore J, Bozzo P, Duckett L, Goldman R, Lin P, Buckmeier J, Alberts DS.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352
    [Abstract] [Full Text] [Related]

  • 17. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
    Mihailovici MS, Teleman S, Ungureanu C.
    Rev Med Chir Soc Med Nat Iasi; 2003 Oct; 107(3):494-501. PubMed ID: 14756051
    [Abstract] [Full Text] [Related]

  • 18. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P, Sanderson RD, Fan CY, Smoller BR.
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.